Antihypertensive pharmacotherapy is evolving with new agents and strategies that enhance individualized care through precision medicine and digital health technologies.
Tasa de eventos absoluta: 0% vs 0%
Hypertension is a leading global cause of morbidity and mortality.4–6, contributing to cardiovascular, renal, and cerebrovascular disease. Antihypertensive pharmacotherapy continues to evolve, with new agents, combination strategies, and device-basedinterventions.18–23 Precision medicine, pharmacogenomics.26–28 and digital health technologies.24–25 are reshaping individualized care. Overview of Major Antihypertensive Drug Classes (Section supported by Goodman & Gilman.1, Katzung2, Rang & Dale.3
Snehal Genbhau Tengle*1, Dr. Amita B. Dongar2, Ms. Ashlesha Gaikwad3 (Fri,) reported a other. Antihypertensive pharmacotherapy is evolving with new agents and strategies that enhance individualized care through precision medicine and digital health technologies.